tiprankstipranks
Trending News
More News >
Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179)
:2179
Hong Kong Market

Compare Jiangsu Recbio Technology Co., Ltd. Class H (2179) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$1.90B
-2.69
-52.12%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$1.93B
238.10
38.89%
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.91B
-47.34
123.11%
1 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.34
HK$8.41B
-18.58
163.18%
1 Buy
0 Hold
0 Sell
Moderate Buy
SinoMab Bioscience Ltd.
HK$1.39
HK$2.35B
-11.90
72.73%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
3.96
-4.31
-52.12%
HK:1875
TOT BIOPHARM International Co. Ltd.
2.50
0.70
38.89%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.33
3.06
134.80%
HK:2616
CStone Pharmaceuticals
5.79
3.70
177.03%
HK:3681
SinoMab Bioscience Ltd.
1.71
0.71
71.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts